I still remember the moment the fee war in ETFs felt finished. Vanguard, BlackRock and State Street had driven core index costs so close to zero that further cuts seemed almost symbolic. Then a San Francisco fintech nobody outside insurance circles had heard of started dropping products at a pace that made veteran portfolio managers do a double take. Nearly two hundred funds in less than a year. Fees that undercut even the aggressive players in buffered and single-stock strategies. And the CEO openly saying artificial intelligence is the only reason the regulatory paperwork could keep up.
The Quiet Arrival of a New ETF Machine
Corgi Invest did not arrive with the usual splash of celebrity endorsements or multi-million-dollar ad campaigns. It simply began filing. One fund after another. Ultrashort bond products. Buffered income strategies. Leveraged single-stock vehicles tied to names that dominate every social feed. By the time most people noticed the ticker symbols appearing on platforms, the count had already climbed past one hundred and ninety.
Nico Laqua, the man running the show, has been remarkably candid about the secret sauce. Highly regulated industries are supposed to be the hardest to disrupt. Paperwork, legal reviews, compliance language, endless back-and-forth with regulators. That is exactly where large language models shine. What used to take teams of lawyers weeks can now be drafted, refined and submitted in days. The result is a product pipeline that looks less like traditional fund manufacturing and more like software shipping.
In my years watching this industry, I have seen plenty of startups promise disruption. Most of them stall once the compliance mountain appears. Corgi appears to have treated that mountain as a coding problem rather than a legal one. Whether that approach scales without eventual regulatory friction remains an open question, but the early numbers are hard to ignore.
Why an Insurance Company Needed Its Own ETFs
The story makes more sense once you understand the parent business. Corgi started as an insurance play. Like every carrier, it collects premiums and must invest the float until claims arrive. Traditional practice meant buying someone else’s funds and paying their expense ratios. Launching an in-house ETF platform turned that cost into an internal transfer. The same vehicles that serve external investors also serve the insurance balance sheet.
That dual use creates an unusual alignment. Lower fees are not just a marketing slogan. They directly improve the economics of the insurance operation. When the company says it can afford to charge thirty basis points on a buffered product while competitors sit closer to seventy, the incentive structure is clear. The more assets the ETFs gather, the cheaper the float becomes to manage.
I find this part of the thesis quietly elegant. Most ETF issuers are pure asset managers. Their only revenue is the fee. Corgi can treat the fee as a secondary benefit while the primary benefit sits on the insurance side of the ledger. That changes the competitive math in ways that pure-play managers cannot easily match.
AI as the Real Accelerator
Laqua has been explicit: without artificial intelligence the current product count would have been impossible on this timeline. Regulatory filings are language-heavy. Prospectuses, statements of additional information, risk disclosures, all of it must meet precise standards. Models trained on previous successful filings can generate first drafts that already sit close to acceptable form. Human reviewers still sign off, of course, but the volume of work they face drops dramatically.
Think about the traditional path. A new buffered strategy might require months of legal drafting, internal compliance cycles, and multiple rounds with the regulators. Multiply that by one hundred and ninety products and the calendar becomes absurd. AI compresses the language generation step so thoroughly that the bottleneck shifts elsewhere—custody, operations, marketing—rather than pure regulatory capacity.
Some industry veterans remain skeptical. They argue that regulators will eventually demand more human accountability and that model-generated text carries hidden risks. Others see the writing on the wall. If the language can be produced faster and still clear every review, the efficiency gain is simply too large to leave on the table. I lean toward the second view, though I will admit the long-term compliance record of these AI-assisted filings will be the real test.
Where the Fee Pressure Hits Hardest
The core index fee war really did reach a practical floor years ago. A few basis points here or there still matter at scale, but the drama has moved. The interesting battles now sit in the higher-fee corners of the market—products that sell protection, leverage, or concentrated bets.
Buffered income funds are a perfect example. These strategies use options to create defined-outcome profiles. Investors accept capped upside in exchange for limited downside. The average expense ratio in the category has hovered around seventy basis points and sometimes higher. Corgi stepped in at thirty. That is not a modest discount. It is a structural reset of the pricing conversation.
Single-stock leveraged products tell a similar story. A two-times Tesla vehicle from the new issuer carries a twenty-basis-point fee. Competing products have charged as much as ninety-five. The difference is large enough that even short-term traders notice it on their statements.
Ultrashort bond funds offer another illustration. These have become popular parking places for cash-like allocations that still seek a bit more yield than pure money markets. The giants already price them aggressively. Corgi still managed to undercut the existing low-cost leaders. When even the cheapest part of the market faces new pressure, the broader message is clear.
Low cost wins in the end. The company is prepared to wait as long as it takes for investors to notice.
That patient stance feels familiar. It is the same posture that carried the original low-cost revolution. Gather assets slowly, keep expenses tight, and let compounding do the rest. The difference this time is the speed of product creation. Waiting for discovery is easier when the shelf is already full.
The Numbers Behind the Ambition
At last count the lineup sat near one hundred and ninety-seven funds. Management has said the total could surpass the largest U.S. issuer before year-end. Whether that claim holds will depend on both the pace of new launches and any withdrawals or mergers that occur along the way. Still, the trajectory is unusual enough to force a recalibration of what “fast” looks like in this industry.
Valuation provides another data point. The parent company recently closed a funding round that placed the overall business at roughly two-point-six billion dollars. That number reflects more than insurance premiums. Investors clearly assigned real option value to the ETF platform and the AI-driven operating model underneath it.
Asset growth remains the missing piece. Launching products is one thing. Gathering meaningful assets under management is another. History shows that many niche ETFs never reach critical scale. Corgi’s bet is that the combination of lower fees and broader product coverage will eventually pull capital. Time will tell whether that conviction proves correct.
What Traditional Issuers Must Now Consider
BlackRock, Vanguard and State Street built their dominance on scale, brand trust and relentless cost discipline. Those advantages remain formidable. Yet the appearance of a competitor that can generate regulatory documents at machine speed changes the competitive surface. Speed of product iteration becomes a new variable.
Existing managers of buffered and single-stock strategies face a more immediate problem. Their higher fee structures suddenly look exposed. Some will cut prices. Others will emphasize track records, liquidity or brand. A few may exit the category entirely if margins compress too far. Consolidation often follows periods of aggressive price competition.
I have spoken with several product strategists at established firms in recent months. The common reaction is a mixture of curiosity and quiet concern. Curiosity about how far the AI workflow can actually stretch. Concern that the barrier to launching complex strategies has dropped more than anyone expected.
Risks That Still Sit on the Table
No disruption story is complete without the counter-arguments. Regulatory scrutiny could intensify once the volume of AI-assisted filings becomes impossible to ignore. Models can hallucinate. Subtle errors in risk disclosure language might only surface years later during market stress. Operational capacity must keep pace with the filing machine. Custody, transfer agency, and daily portfolio management all require real infrastructure.
Investor behavior is another unknown. Lower fees help, but many buyers of buffered or leveraged products are not pure cost minimizers. They respond to marketing, social proof, and perceived sophistication. A new brand still has to earn trust the old-fashioned way.
There is also the question of concentration risk inside the insurance parent. If the float is heavily allocated to the same ETFs that the firm is promoting externally, any performance shortfall becomes a double hit. Management has described the dual use as a strength. Outside observers will watch carefully for signs that the two roles ever conflict.
How the Product Mix Reflects a Clear Strategy
Look closely at the lineup and a pattern emerges. Core exposures exist—ultrashort bonds, intermediate treasuries—but the real density sits in higher-fee categories where the pricing disruption is most dramatic. Buffered outcomes. Single-name leverage. Thematic sector bets with leverage. These are the areas where traditional competitors still enjoy healthier margins and where a new entrant can create the most immediate noise.
The approach feels deliberate. Rather than trying to win the pure index war that has already been fought, the firm is attacking the flanks. Capture share where fees remain elevated, use the resulting scale to support further launches, and let the insurance float provide a captive base of assets while the public franchise grows.
I find the thematic and leveraged sleeves particularly interesting. Investor appetite for concentrated technology and artificial-intelligence exposure remains strong. Offering those bets at meaningfully lower costs could attract a different slice of the market than pure index funds ever reach.
The Longer Game of Asset Gathering
Laqua has said the company is willing to wait. That patience may prove necessary. Brand recognition in the ETF world is sticky. Advisors and individual investors tend to default to names they already know. Building distribution relationships, securing platform placements, and generating organic search traffic all take time.
Yet the structural advantage remains. Every basis point of fee savings compounds. Over a decade the difference between thirty and seventy basis points on a buffered strategy is material. Investors who notice the gap and stay invested will generate better outcomes simply by paying less. That truth has driven the entire low-cost revolution. There is little reason to believe it has suddenly stopped working.
Perhaps the most interesting aspect is the feedback loop between insurance and asset management. As the ETFs grow, the float becomes cheaper to manage. As the float grows with the insurance business, the ETFs receive a steady stream of patient capital. Few traditional managers enjoy that kind of closed-loop support.
What This Means for Everyday Investors
For individuals the practical implication is straightforward. More choice at lower prices in categories that used to feel expensive. Buffered strategies no longer require accepting a seventy-basis-point drag as the cost of downside protection. Single-stock leverage becomes less punitive on the fee side. Even cash-like allocations have a new low-cost option.
That does not mean every product is appropriate for every portfolio. Leverage cuts both ways. Defined-outcome funds still embed path dependency and opportunity cost. The existence of a cheaper version does not change the underlying risk profile. It simply removes one unnecessary layer of cost.
I have always believed that fees are one of the few variables investors can control with certainty. When a new provider arrives and systematically undercuts existing prices across multiple categories, the rational response is to examine the lineup carefully rather than dismiss it on brand grounds alone.
Looking Ahead at the Competitive Landscape
Will Corgi actually become the largest issuer by product count? The claim is bold and the calendar is short. Even if the pure number is reached, assets under management will tell a more meaningful story. Product count without scale is an interesting footnote. Product count with growing assets becomes a structural shift.
Other fintechs and traditional managers are watching. Some will accelerate their own use of language models for regulatory work. Others will double down on brand, service and liquidity advantages that a newcomer cannot match overnight. The net result is likely to be faster product cycles across the industry and continued pressure on fees in the non-core categories.
In my experience, once a genuine cost advantage appears and proves durable, the rest of the market eventually adjusts. The original fee war did not end because the giants decided to stop competing. It slowed because the practical floor had been reached. A new floor is now being tested in different parts of the market.
The Broader Signal About Technology and Finance
Step back from the specific tickers and the story becomes larger. Regulated financial products have long been considered resistant to the kind of rapid iteration common in software. The combination of AI language generation and a captive capital base appears to have cracked that resistance, at least for now.
If the model holds, we should expect more experiments that treat compliance language as a solvable engineering problem rather than an immutable cost of doing business. That shift could reshape not only ETFs but other product categories that live and die by regulatory filings.
Of course the experiment is still young. The real test will come during the next period of market stress, when every disclosure is scrutinized and every operational process is stretched. Until then the industry has a new data point: a VC-backed insurance company used artificial intelligence to flood the market with low-cost ETFs and openly declared its intention to challenge the product-count leader.
Whether that challenge ultimately succeeds on assets as well as product count remains to be seen. What is already clear is that the old assumption about the fee war being finished was premature. A new chapter has opened, and the tools powering it look very different from the ones that fought the last round.
Investors who care about costs have one more reason to keep their product lists updated. The shelf just got longer, and in several important categories the price tags just got smaller. That combination rarely stays quiet for long.
